Hypochlorite scavenging activity of cerium oxide nanoparticles

G. Pulido-Reyesa, S. Dasb, F. Leganésa, S. O. Silvac, S. Wud, W. Selfe, F. Fernández-Piñasa, R. Rosal*f and S. Seal*bg
aDepartamento de Biología, Facultad de Ciencias, Universidad Autónoma de Madrid, E-28049, Spain
bAdvanced Materials Processing and Analysis Center, NanoScience and Technology Center, Materials Science and Engineering, University of Central Florida, Orlando, FL 32816, USA. E-mail: Sudipta.Seal@ucf.edu
cDepartamento de Ciências Básicas da Saúde, Universidade Estadual de Maringá, 87020-900 Maringá, PR, Brazil
dDepartment of Applied Chemistry, National Chiao Tung University, Hsinchu, Taiwan 300, Republic of China
eBurnett School of Biomedical Science, College of Medicine, University of Central Florida, USA
fDepartamento de Ingeniería Química, Universidad de Alcalá, E-28871, Alcalá de Henares, Madrid, Spain. E-mail: roberto.rosal@uah.es
gCollege of Medicine, University of Central Florida, USA

Received 29th April 2016 , Accepted 23rd June 2016

First published on 24th June 2016


Abstract

In this report, we provide evidence that specific synthesis of cerium oxide nanoparticles can scavenge the hypochlorite anion, which is a strong extracellular oxidant involved in the inflammatory processes. The scavenging process takes place by a surface reaction involving the evolution of oxygen and the reduction of Ce4+ to Ce3+.


Reactive oxygen species (ROS) or oxidants are associated with different diseases and aging.1 Among them, HOCl/ClO is a strong oxidant produced by activated neutrophils and monocytes. Activated neutrophils or monocytes produce myeloperoxidase, which reacts with hydrogen peroxide and chloride ions giving rise to hypochlorous acid, HOCl, a strong non-selective oxidant.2,3 HOCl production is part of the host defense mechanism against microorganisms; however, these properties may involve the risk of tissue damage through the same processes used in the destruction of invading microorganisms. In fact, neutrophil oxidants have been shown to be implicated in the tissue injury associated with inflammatory diseases, including respiratory distress, ischemia–reperfusion injury, acute vasculitis, arthritis, inflammatory bowel diseases, and glomerulonephritis.4

Antioxidant and some natural compounds have been shown to scavenge hypochlorite such as flavonoids, polyphenols, hydroxycinnamic acids, etc.5–8 Cerium oxide nanoparticles (CNPs) have recently been shown as an inorganic regenerative antioxidant in biological systems.9 CNPs are characterized by a complex redox chemistry due to the presence of Ce3+ atoms accompanying oxygen vacancies which are surrounded by Ce4+ atoms.10 It has been reported that CNPs display superoxide-dismutase mimetic activity,9 catalase mimetic activity11 and the capacity to scavenge nitric oxide radicals.12 Therefore, CNPs could potentially be used in biomedicine to fight against oxidative stress.

Although there are studies which describe the antioxidant properties of CNPs,13,14 in particular superoxide radical, hydrogen peroxide, hydroxyl radical and nitric oxide/peroxynitrite radical, in general, the antioxidant activity of these nanoparticles has been measured indirectly by intermediaries15,16 and the reactions and subproducts which are generated after the interaction between CNPs and free radicals have not been fully characterized. Moreover, until now, there has been no evidence that CNPs can scavenge HOCl/ClO. A complete knowledge of the interaction of all physiological compounds with CNPs is completely necessary before assessing the massive use of CNPs in biomedical applications. In this study, we investigated whether CNPs are capable of scavenging HOCl/ClO and explored the reaction mechanism by which this phenomenon occurs. The proposed scavenging method which is shown here improves the speed of scavenging reaction of this particular ROS in comparison with already published articles17 and clearly shows that it is effective in an in vitro cell model.

It is well established that physicochemical properties of CNPs govern the catalytic activity. Therefore, in this study we have selected four different CNPs (synthesized or commercially available) which have been used in previous studies and named as CNP1,18 CNP2,19 CNP3[thin space (1/6-em)]12 and CNP4.18 Physicochemical properties of the four nanoparticles were thoroughly analyzed and summarized in Table 1. In particular, size, morphology, agglomeration status, surface charge and surface Ce3+/Ce4+ were measured. These above mentioned parameters were investigated as catalytic activity of CNPs can be highly influenced by these parameters as follows: (1) size – directly correlated with surface area and density of active site; (2) morphology and crystallinity – surface energy and stability of the particles; (3) agglomeration status – directly correlated with available surface for catalytic activity; (4) surface Ce3+/Ce4+ – the presence of both surface oxidation states at nanoscale make nanoparticles catalytically active, CNPs with higher Ce3+/Ce4+ scavenge more superoxide radicals whereas lower Ce3+/Ce4+ scavenge hydrogen peroxide and nitric oxide radicals.20 The size and morphology of particles were assessed using High Resolution Transmission Electron Microscopy (HRTEM). They were all round-shaped with particle nominal size in the 3–20 nm range. The selected area electron diffraction (SAED) pattern revealed that all four particles were crystalline (HRTEM images and SAED pattern are shown in the supplementary document, ESI Fig. S1).

Table 1 Physicochemical characterization of CNPs
Sample Surface Ce3+ (%) Shape ζ-Potential (mV) Effective diameter (DLS) (nm)
CNP1 27 Round 52.3 ± 0.5 50.8 ± 0.9
CNP2 40 Round 56.5 ± 1.4 58.8 ± 0.8
CNP3 30 Round 46.0 ± 2.5 9.4 ± 2.1
CNP4 57 Round 18.6 ± 0.6 30.8 ± 2.8


Effective diameter and zeta-potential of the CNPs suspensions were measured by dynamic light scattering (DLS) and electrophoretic light scattering, respectively (Zetasizer Nano ZS from Malvern Instruments). The data, obtained for 1 mM suspensions in high purity water at pH 7.5, are shown in Table 1. X-ray photoelectron spectroscopy data were collected for Ce 3d5/2 using 5400 PHI ESCA spectrometer (Mg-Kα X-radiation (1253.6 eV) at a power of 350 W was used during the data collection). Surface Ce3+/Ce4+ was calculated as discussed in our previous publication.21

These well characterized nanoparticles were investigated for ClO scavenging activity. The nanoparticle suspensions (from 0.1 to 4 mM) were incubated for 60 min with freshly prepared hypochlorite solutions (5 mM, pH 9.0 ± 0.2). Then, the particles were separated by centrifugation (23[thin space (1/6-em)]000g, 5 min). The amount of ClO (at the working pH, hypochlorous acid, pKa 7.5, is 97% dissociated) in the supernatant, which decreased due to the scavenging activity of CNPs, was tracked by measuring the inactivation of catalase. The method followed the procedure described by Aruoma and Halliwell22 with minor variations. The scavenging activity was evaluated by measuring the decrease in absorbance of catalase at 404 nm using microplate readings (FLUOstar Omega microplate reader, BMG LABTECH, Germany). The data are shown in Fig. 1A for the tested CNPs and the reference antioxidant compound ascorbic acid.23 Scavenging activity (%) was calculated using the following formula [1].

 
image file: c6ra11131a-t1.tif(1)
where Ct1 is the catalase absorbance (measured at 404 nm) without ClO (intact catalase); Ct2 is the catalase absorbance in the presence of ClO (degraded catalase) and Cx is the catalase absorbance with ClO which was previously in contact with CNPs or ascorbic acid.


image file: c6ra11131a-f1.tif
Fig. 1 (A) ClO scavenging activity of CNP determined from catalase inactivation measurements. (B) UV-Vis spectra showing the interaction of CNP3 and ClO. (C) Kinetics of ClO depletion by CNP3.

The data show that CNP3 has strong ClO scavenging activity, with reaction extents comparable to the same concentration of ascorbic acid. The interaction of CNP3 with ClO was revealed by absorption spectroscopy. The absorption spectra of CNP3, recorded using a Perkin Elmer Lambda 750S instrument, show a shift in the absorption peak from 300 to 322 nm in CNP exposed to ClO (60 min), separated by centrifugation and carefully washed three times before recording the spectrum (Fig. 1B). A similar phenomenon was found with CNP2 (see ESI Fig. S2). Absorbance values at wavelengths 298 and 252 nm are the characteristic UV-Vis absorbance for Ce4+ and Ce3+, respectively.24 Fig. 1B clearly indicates that there is a shift in CNPs surface oxidation state from Ce4+ to Ce3+ after reacting with ClO. The disappearance of ClO from CNPs suspensions could not be attributed to its mere adsorption on the nanoparticle surface. A kinetic study was undertaken in mixtures of ClO and CNPs (5 mM) by following the evolution of hypochlorite concentration with time. The UV absorbance at 292 nm (molar absorptivity 350 M−1 cm−1) was measured to estimate the concentration of the ClO on the supernatant of centrifuged samples.25 The corresponding data are shown in Fig. 1C for CNP3. We selected CNP3 as CNP3 showed highest ClO scavenging activity. A Langmuir kinetics assuming surface equilibrium yields the following expression:26

 
r = kKC/(1 + KC) (2)
where k is the rate of reaction of adsorbed species, K the adsorption equilibrium constant and C is the concentration of ClO. Given the relatively low concentration used, the zero-order kinetics depicted in Fig. 1C points towards a high adsorption constant of ClO on CNP.

In order to better understand the interaction between ClO and CNP, XPS analysis was performed to further confirm the change in Ce3+/Ce4+ on the surface of the nanoparticles seen in UV-Vis data. CNP3 was washed three times with distilled water after 60 min treatment with 5 mM ClO, to make sure there was no free ClO. The Ce 3d5/2 spectra recorded (Fig. 2A and B) showed a significant increase in surface Ce3+ (12%) after interaction of CNP3 with ClO for 60 min at pH 9.0. The presence of chloride on CNP3 surface after treatment with ClO is also apparent (Fig. 2C). The shift in Cl 2P3/2 spectrum compared to CeCl3 may signify a complex formation on the surface of the nanoparticles rather than formation of CeCl3 on the surface. Based on these results, we hypothesized the following reaction by means of which ClO is depleted by interaction with CNP3:

 
Ce4+ + 2ClO → Ce3+ + 2Cl + O2 (3)


image file: c6ra11131a-f2.tif
Fig. 2 The chemical property of the CNP3 after treatment with ClO. (A) and (B) show a significant change in Ce 3d5/2 XPS spectrum after treatment with ClO. (C) Shows Cl 2p3/2 spectra of CNPs, CNPs treated with ClO and CeCl3 (CeCl3 was used as reference) and indicates the presence of Cl on the surface of the nanoparticles after reaction of ClO.

The reaction accounts for the formation of chlorine–metal bonds due to chloride adsorption on the positively charged surface and should be accompanied by a release of oxygen. In order to prove that ClO decomposes as indicated, we performed direct measurements of oxygen evolution using a Clark-type oxygen electrode. The experiments were performed at 25 °C under constant stirring (0.1 g) using a Hansatech apparatus (Kings Lynn, Norfolk, UK) with 1 mM CNPs and 5 mM of ClO.

The results are shown in Fig. 3 and revealed a significant evolution of oxygen for CNP3 (CNP4 and ClO without nanoparticles are also shown for comparison), which amounted to 8 nmol min−1 or 0.32 mol O2 mol per CNP per h. There was no evidence of oxygen release when nanoparticle or ClO alone was added (ESI Fig. S3). Lastly, we explored if CNP could scavenge ClO in the cellular environment. RAW 264.7 cells culture was selected as in vitro model and boron dipyrromethene-based fluorometric probe, HCS, was used to detect the ClO.27 Data are shown in Fig. 4. Confocal images clearly indicate that concentration of ClO in the cells pre-treated with CNP3 is comparable to the control. 1 μM concentration of CNP3 was sufficient to scavenge the ClO to its basal level (control) in the RAW cell model. Fluorescence intensity was also measured using Image J software and is shown in ESI Fig. S4.


image file: c6ra11131a-f3.tif
Fig. 3 Oxygen evolution for CNP in contact with ClO.

image file: c6ra11131a-f4.tif
Fig. 4 Scavenging of ClO by CNP3 in vitro RAW cell culture model. Pretreatment with 1 μM CNP3 able to scavenge the most of the ClO (comparable to control); scale bar 50 μm.

Conclusions

The higher activity of CNP3 in comparison with the other tested nanoparticles is apparent from the data displayed in Fig. 1–3. We attributed this higher reactivity to its significantly lower effective particle size, with DLS diameters below 10 nm versus 30–50 nm for the other particles and to higher Ce4+ on the surface. The effect of particle size on surface chemistry has already been reported for CNPs.28 Decrease in nanoparticles size and increase in stability are directly related to increase in the active surface area for the reaction.9 From the proposed reaction and XPS data it can be concluded that higher surface Ce4+ is necessary for better ClO scavenging. It is interesting to mention that CNP1 (73%) has a comparable amount of Ce4+ to that of CNP3 (70%) and similar nominal size (5–8 nm); however, CNP3 has the highest scavenging activity. Thus, lower stability of CNP1 (higher agglomeration, Table 1) contributed towards lower ClO scavenging activity. Noteworthy, CNP2, which also showed a minor surface interaction as revealed by absorption spectroscopy, had a surface composition very similar to that of CNP1. In conclusion, we determined that CNPs were able to scavenge ClO both in test tube and in vitro RAW cell culture model by surface interaction and a reaction involving the evolution of oxygen and the reduction of Ce4+ to Ce3+. The results are relevant because HOCl/ClO is involved in tissue damage due to overstimulation of inflammatory processes.

Acknowledgements

This research was supported by the Ministry of Economy of Spain (CTM2013-45775-C2-1-R/2-R) and the Dirección General de Universidades e Investigación de la Comunidad de Madrid, Research Network S2013/MAE-2716. Dr Sueli de Oliveira Silva acknowledges Capacitação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)-Brazil for support. Gerardo Pulido-Reyes thanks the Spanish Ministry of Education for the award of a FPU grant.

Notes and references

  1. A. A. Alfadda and R. M. Sallam, J. Biomed. Biotechnol., 2012, 2012, 936486 CrossRef PubMed.
  2. L. J. Palmer, P. R. Cooper, M. R. Ling, H. J. Wright, A. Huissoon and I. L. C. Chapple, Clin. Exp. Immunol., 2012, 167, 261–268 CrossRef CAS PubMed.
  3. S. M. McKenna and K. J. Davies, Biochem. J., 1988, 254, 685–692 CrossRef CAS PubMed.
  4. J. D. Imig and M. J. Ryan, Compr. Physiol., John Wiley & Sons, Inc., 2013 Search PubMed.
  5. B. Bekdeser, N. Durusoy, M. Ozyurek, K. Guclu and R. Apak, J. Agric. Food Chem., 2014, 62, 11109–11115 CrossRef CAS PubMed.
  6. O. Firuzi, P. Mladenka, R. Petrucci, G. Marrosu and L. Saso, J. Pharm. Pharmacol., 2004, 56, 801–807 CrossRef CAS PubMed.
  7. O. Firuzi, L. Giansanti, R. Vento, C. Seibert, R. Petrucci, G. Marrosu, R. Agostino and L. Saso, J. Pharm. Pharmacol., 2003, 55, 1021–1027 CrossRef CAS PubMed.
  8. J. Pedraza-Chaverri, G. Arriaga-Noblecia and O. N. Medina-Campos, Phytother. Res., 2007, 21, 884–888 CrossRef PubMed.
  9. S. Das, J. M. Dowding, K. E. Klump, J. F. McGinnis, W. Self and S. Seal, Nanomedicine, 2013, 8, 1483–1508 CrossRef CAS PubMed.
  10. F. Esch, S. Fabris, L. Zhou, T. Montini, C. Africh, P. Fornasiero, G. Comelli and R. Rosei, Science, 2005, 309, 752–755 CrossRef CAS PubMed.
  11. E. G. Heckert, A. S. Karakoti, S. Seal and W. T. Self, Biomaterials, 2008, 29, 2705–2709 CrossRef CAS PubMed.
  12. J. M. Dowding, T. Dosani, A. Kumar, S. Seal and W. T. Self, Chem. Commun., 2012, 48, 4896–4898 RSC.
  13. J. Chen, S. Patil, S. Seal and J. F. McGinnis, Nat. Nanotechnol., 2006, 1, 142–150 CrossRef CAS PubMed.
  14. J. M. Perez, C. Kaittanis, A. Asati and S. Santra, US 8795731 B1, 2014.
  15. S. Soren, S. R. Jena, L. Samanta and P. Parhi, Appl. Biochem. Biotechnol., 2015, 177, 148–161 CrossRef CAS PubMed.
  16. S. Chigurupati, M. R. Mughal, E. Okun, S. Das, A. Kumar, M. McCaffery, S. Seal and M. P. Mattson, Biomaterials, 2013, 34, 2194–2201 CrossRef CAS PubMed.
  17. Z. Liu, Y. Yan, S. Wang, W.-Y. Ong, C. N. Ong and D. Huang, Am. J. Biomed. Sci, 2013, 2, 140–153 CrossRef.
  18. S. Das, S. Singh, J. M. Dowding, S. Oommen, A. Kumar, T. X. Sayle, S. Saraf, C. R. Patra, N. E. Vlahakis, D. C. Sayle, W. T. Self and S. Seal, Biomaterials, 2012, 33, 7746–7755 CrossRef CAS PubMed.
  19. T. Sakthivel, S. Das, A. Kumar, D. L. Reid, A. Gupta, D. C. Sayle and S. Seal, ChemPlusChem, 2013, 78, 1446–1455 CrossRef CAS.
  20. A. Kumar, S. Das, P. Munusamy, W. Self, D. R. Baer, D. C. Sayle and S. Seal, Environ. Sci.: Nano, 2014, 1, 516–532 RSC.
  21. S. Deshpande, S. Patil, S. V. N. T. Kuchibhatla and S. Seal, Appl. Phys. Lett., 2005, 87, 133113 CrossRef.
  22. O. I. Aruoma and B. Halliwell, Biochem. J., 1987, 248, 973–976 CrossRef CAS PubMed.
  23. S. Shukla, A. Mehta, V. K. Bajpai and S. Shukla, Food Chem. Toxicol., 2009, 47, 2338–2343 CrossRef CAS PubMed.
  24. C. J. Neal, S. Das, S. Saraf, L. Tetard and S. Seal, ChemPlusChem, 2015, 80, 1680–1690 CrossRef CAS.
  25. J. Zhang, X. Xu and X. Yang, Analyst, 2012, 137, 3437–3440 RSC.
  26. Y. Liu and L. Shen, Langmuir, 2008, 24, 11625–11630 CrossRef CAS PubMed.
  27. S.-R. Liu, M. Vedamalai and S.-P. Wu, Anal. Chim. Acta, 2013, 800, 71–76 CrossRef CAS PubMed.
  28. S. V. Kuchibhatla, A. S. Karakoti, D. R. Baer, S. Samudrala, M. H. Engelhard, J. E. Amonette, S. Thevuthasan and S. Seal, J. Phys. Chem. C, 2012, 116, 14108–14114 CrossRef CAS PubMed.

Footnote

Electronic supplementary information (ESI) available. See DOI: 10.1039/c6ra11131a

This journal is © The Royal Society of Chemistry 2016
Click here to see how this site uses Cookies. View our privacy policy here.